$162.69
2.50%
Nasdaq, Nov 17, 04:00 pm EST. Closed.
ISIN
US76155X1000
Symbol
RVMD

Revolution Medicines Inc Target price 2026 - Analyst rating & recommendation

Revolution Medicines Inc Classifications & Recommendation

Buy
94%
Hold
6%

Revolution Medicines Inc Price Target

Target Price $265.20
Price $162.69
Potential
Number of Estimates 26
26 Analysts have issued a price target Revolution Medicines Inc 2027 . The average Revolution Medicines Inc target price is $265.20. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 31 analysts: 29 Analysts recommend Revolution Medicines Inc to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Revolution Medicines Inc stock has an average upside potential 2027 of . Most analysts recommend the Revolution Medicines Inc stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ ??? ???
??? ???

27 Analysts have issued a sales forecast Revolution Medicines Inc 2026 . The average Revolution Medicines Inc sales estimate is

. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .

This results in the following potential growth metrics:

Revenue Estimates

2025 $0.0
2027
2028
2029
2030
2031
2032
2033

10 Analysts have issued an Revolution Medicines Inc EBITDA forecast 2026. The average Revolution Medicines Inc EBITDA estimate is

. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-1.2b 72.12%
2026
2027
2028
2029
2030
2031
2032
2033

EBITDA Margin

2027
2028
2029
2030
2031
2032
2033

28 Revolution Medicines Inc Analysts have issued a net profit forecast 2026. The average Revolution Medicines Inc net profit estimate is

. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-1.1b 88.52%
2026
2027
2028
2029
2030
2031
2032
2033

Net Margin

2027
2028
2029
2030
2031
2032
2033

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ ??? ???
??? ???
P/E ???
EV/Sales ???

28 Analysts have issued a Revolution Medicines Inc forecast for earnings per share. The average Revolution Medicines Inc EPS is

. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-5.95 66.20%
2026
2027
2028
2029
2030
2031
2032
2033

P/E ratio

Current -46.48 81.12%
2026
2027
2028
2029
2030
2031
2032
2033

Based on analysts' sales estimates for 2026, the Revolution Medicines Inc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 169.58
2026
2027
2028
2029
2030
2031
2032
2033

P/S ratio

Current
2026
2027
2028
2029
2030
2031
2032
2033

Current Revolution Medicines Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
Analyst Rating Date
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today